The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Photodynamic Therapy Using Topical Methyl Aminolevulinate vs Surgeryfor Nodular Basal Cell Carcinoma: Results of a Multicenter Randomized Prospective Trial
Abstract
BACKGROUND: Photodynamic therapy (PDT) is increasingly used as a noninvasive treatment for nodular basal cell carcinoma (BCC), without a sound evidence base. OBJECTIVE: To compare topical PDT, with the use of the sensitizer methyl aminolevulinate, and standard excision surgery in nodular BCC. DESIGN: Prospective, randomized study. SETTING: University dermatology departments. PATIENTS: A total of 101 adults with previously untreated nodular BCC. INTERVENTIONS: Patients received methyl aminolevulinate PDT (n = 52) or surgery (n = 49). The PDT was given twice, 7 days apart, with methyl aminolevulinate cream (160 mg/g) and 75 J/cm(2) red light (570-670 nm). Thirteen patients with a noncomplete response to PDT at 3 months (24% lesions) were retreated. OUTCOME MEASURES: Primary end point was clinically assessed lesion clearance at 3 months after treatment. Secondary end points were sustained response rate at 12 months and cosmetic outcome at 3 and 12 months. Cosmesis and lesion recurrence were further assessed at 24 months. RESULTS: Data from 97 patients (105 lesions) were included in the 3-month per-protocol analysis. Complete response rates did not differ significantly between groups (51/52 [98%] lesions with surgery vs 48/53 [91%] lesions with methyl aminolevulinate PDT; difference [95% confidence interval], 4.8% (-3.4% to 13.0%]; P =.25). At 12 months, tumor-free rates were 50 (96%) of 52 lesions with surgery vs 44 (83%) of 53 with methyl aminolevulinate PDT (P =.15). More patients treated with methyl aminolevulinate PDT than surgery had an excellent or good cosmetic outcome at all time points (significant at 12 and 24 months on patient assessment, P<.05, and at 3, 12, and 24 months on investigator evaluation, P<.001). At 24 months, 5 lesions that had initially cleared with methyl aminolevulinate PDT had recurred, compared with 1 after surgery. CONCLUSIONS: Methyl aminolevulinate PDT is an effective treatment for nodular BCC, and while there is a trend for higher recurrence with this modality, it conveys the advantage over surgery of better cosmesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guidelines for the management of basal cell carcinoma
Telfer, N. R., Colver, G. B., & Morton, C. A. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08666.x · Cited by 960
ROWE, D. E., CARROLL, R. J., & JR. DAY, C. L. (1989) · The Journal of Dermatologic Surgery and Oncology · doi:10.1111/j.1524-4725.1989.tb03166.x · Cited by 802
Morton, C. A., Brown, S. B., Collins, S., Ibbotson, S., Jenkinson, H., Kurwa, H., Langmack, K., Mckenna, K., Moseley, H., Pearse, A. D., et al. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.04719.x · Cited by 451
Self-citationA Systematic Review of Treatment Modalities for Primary Basal Cell Carcinomas
Thissen, M. R. T. M., Neumann, M. H. A., & Schouten, L. J. (1999) · Archives of Dermatology · doi:10.1001/archderm.135.10.1177 · Cited by 388
Guidelines for the management of basal cell carcinoma
Telfer, Colver, & Bowers (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.03033.x · Cited by 339
Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial
Wang, I., Bendsoe, N., Klinteberg, C. A., Enejder, A. M. K., Andersson-Engels, S., Svanberg, S., & Svanberg, K. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04141.x · Cited by 309
Estimates of ozone depletion and skin cancer incidence to examine the Vienna Convention achievements
Slaper, H., Velders, G. J. M., Daniel, J. S., de Gruijl, F. R., & van der Leun, J. C. (1996) · Nature · doi:10.1038/384256a0 · Cited by 297
Recurrence Rates of Treated Basal Cell Carcinomas: Part 3: Surgical Excision
SILVERMAN, M. K., KOPF, A. W., BART, R. S., GRIN, C. M., & LEVENSTEIN, M. S. (1992) · The Journal of Dermatologic Surgery and Oncology · doi:10.1111/j.1524-4725.1992.tb03307.x · Cited by 251
Nambour Study Group, Green, A., Battistutta, D., Hart, V., Leslie, D., & Weedon, D. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008875 · Cited by 242
Soler, A. M., Warloe, T., Berner, A., & Giercksky, K. E. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04407.x · Cited by 219
Fritsch, C., Homey, B., Stahl, W., Lehmann, P., Ruzicka, T., & Sies, H. (1998) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1998.tb02492.x · Cited by 192 · cited 1×
“of adverse events 61 24 Any local adverse event First cycle, first treatment 20/52 (38) 8/49 (16) First cycle, second treatment 18/49 (37) NA Second cycle, first treatment 1/12 (8) NA Second cycle, second treatment 3/10 (30) NA Common local adverse events* Burning sensation of skin 16 (31) 0 Pain in skin 7 (14) 3 (6)…”
BackgroundProdrugs of 5‐Aminolevullinic Acid for Photodynamic Therapy
Kloek, J., & Beijersbergen van Henegouwen, G. M. J. (1996) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1996.tb01868.x · Cited by 182
Jeffes, E. W. (1997) · Archives of Dermatology · doi:10.1001/archderm.133.6.727 · Cited by 177
Photodynamic Therapy in the Treatment of Cancer: Current State of the Art
Hsi, R. A., Rosenthal, D. I., & Glatstein, E. (1999) · Drugs · doi:10.2165/00003495-199957050-00005 · Cited by 175
Recurrence Rates of Treated Basal Cell Carcinomas: Part 1: Overview
SILVERMAN, M. K., KOPF, A. W., GRIN, C. M., BART, R. S., & LEVENSTEIN, M. J. (1991) · The Journal of Dermatologic Surgery and Oncology · doi:10.1111/j.1524-4725.1991.tb03424.x · Cited by 170
Szeimies, R., Karrer, S., Sauerwald, A., & Landthaler, M. (2009) · Dermatology · doi:10.1159/000246376 · Cited by 149
Recurrence Rates of Treated Basal Cell Carcinomas
HIRSCH, P., Silverman, M. K., & Kopf, A. W. (1993) · The Journal of Dermatologic Surgery and Oncology · doi:10.1111/j.1524-4725.1993.tb03456.x · Cited by 146
Incidence of nonmelanoma skin cancer in the United States
Clayson, D. B. (1984) · Cancer Letters · doi:10.1016/0304-3835(84)90124-1 · Cited by 142
National Cancer Institute-Common Toxicity Criteria
下山正徳 (1999) · 癌と化学療法 · Cited by 132
Haller, J. C., Cairnduff, F., Slack, G., Schofield, J., Whitehurst, C., Tunstall, R. G., Brown, S. B., & Roberts, D. J. H. (2000) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2000.04000.x · Cited by 106
The Epidemiology of Non‐Melanoma Skin Cancer: Who, Why and What Can We Do about It
Marks, R. (1995) · The Journal of Dermatology · doi:10.1111/j.1346-8138.1995.tb03935.x · Cited by 103
Fink‐Puches, R., Hofer, A., Smolle, J., Kerl, H., & Wolf, P. (1997) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/s1011-1344(97)00096-1 · Cited by 91
Self-citationSoler, A. (1999) · Acta Dermato Venereologica · doi:10.1080/000155599750010977 · Cited by 86
5-Aminolevulinic acid-based photodynamic therapy
(1997) · doi:10.1002/(sici)1097-0142(19970615)79:12<2282::aid-cncr2>3.0.co;2-o
Cited by
Photodynamic therapy of cancer: An update
Agostinis, P., Berg, K., Cengel, K. A., Foster, T. H., Girotti, A. W., Gollnick, S. O., Hahn, S. M., Hamblin, M. R., Juzeniene, A., Kessel, D., et al. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20114 · Cited by 5,145
Clinical development and potential of photothermal and photodynamic therapies for cancer
Li, X., Lovell, J. F., Yoon, J., & Chen, X. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0410-2 · Cited by 3,456
The present and future role of photodynamic therapy in cancer treatment
Brown, S. B., Brown, E. A., & Walker, I. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01529-3 · Cited by 1,771
In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers
Idris, N. M., Gnanasammandhan, M. K., Zhang, J., Ho, P. C., Mahendran, R., & Zhang, Y. (2012) · Nature Medicine · doi:10.1038/nm.2933 · Cited by 1,464
Nanoparticles in photodynamic therapy: An emerging paradigm
Chatterjee, D. K., Fong, L. S., & Zhang, Y. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.003 · Cited by 1,184
Metadata
- Authors
- Rhodes, L. E., de Rie, M., Enström, Y., Groves, R., Morken, T., Goulden, V., Wong, G. A. E., Grob, J.-J., Varma, S., & Wolf, P.
- Venue
- Archives of Dermatology
- Publisher
- American Medical Association (AMA)
- Published
- 2004-01-01
- Volume
- 140
- Issue
- 1
- Pages
- 17-23
- ISSN
- 0003-987X (ISSN-L)
- OpenAlex
- W2130465532
- Cited by
- 355
- References
- 24
- FWCI
- 20.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.